Reta 30 features a proprietary engineered analog of native GLP-1, GIP, and glucagon. It is used in metabolic and endocrinology research to investigate effects on body weight reduction, energy expenditure, appetite control, and glycemic modulation through insulin sensitization. It is supplied as high-purity lyophilized peptide powder for consistent research outcomes.